EyeYon Medical develops and brings to market exclusive medical ophthalmic devices, which offer relief to unmet clinical need for millions of patients. Its innovative technologies are proven in clinical studies.
EyeYon’s first product, Hyper-CL™, a therapeutic contact lens for treating corneal edema, has received the CE Mark and FDA 510(k) clearance, and is approved for marketing in Europe, the USA and additional territories.
EyeYon’s future product, the EndoArt® is an artificial endothelial layer that cures corneal edema using an implant made of silicon film attached to the posterior corneal surface. The EndoArt® is in pre-clinical stage and has demonstrated promising results in animal trials.
EyeYon’s first product, Hyper-CL™, a therapeutic contact lens for treating corneal edema, has received the CE Mark and FDA 510(k) clearance, and is approved for marketing in Europe, the USA and additional territories.
EyeYon’s future product, the EndoArt® is an artificial endothelial layer that cures corneal edema using an implant made of silicon film attached to the posterior corneal surface. The EndoArt® is in pre-clinical stage and has demonstrated promising results in animal trials.
Location: Israel, Central, Ness Ziona
Employees: 11-50
Phone: +972 73-780-3607
Total raised: $31.5M
Founded date: 2011
Investors 4
| Date | Name | Website |
| 05.07.2025 | Triventure... | triventure... |
| - | Quark Vent... | quarkventu... |
| - | Diamond Bi... | diamondbio... |
| - | Pontifax V... | pontifax.c... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 15.03.2021 | Series C | $25M | - |
| 21.03.2017 | - | $6.5M | - |
Mentions in press and media 6
| Date | Title | Description |
| 05.02.2025 | EyeYon Medical Expands into China with New Subsidiary | ZHUHAI, China, Feb. 5, 2025 /PRNewswire/ -- EyeYon Medical is proud to announce its expansion in China with the establishment of a new subsidiary, Zhuhai EyeYon Medical Technology Co., Ltd. (珠海爱眼医疗科技有限公司), which will address unmet market ne... |
| 16.08.2022 | Scientists say India’s first 3D printed cornea “can be used in humans” after successful animal trial | A cornea 3D printed at India’s L V Prasad Eye Institute (LVPEI), Indian Institute of Technology (IIT) Hyderabad and Centre for Cellular and Molecular Biology has been successfully animal tested for the first time. Made from a bio-ink derive... |
| 23.03.2022 | Israeli surgeons carry out “world’s thinnest 3D printed cornea” transplant | Surgeons at Israel’s Shaare Zedek Medical Center (SZMC) have successfully transplanted the world’s thinnest artificial cornea into the eye of a patient, according to a Jerusalem Post report. Developed by medical device manufacturer EyeYon, ... |
| 15.03.2021 | EyeYon Medical Raises $25 million in Series C to Transform Corneal Care | TEL AVIV, Israel, March 15, 2021 /PRNewswire/ -- EyeYon Medical announced today the completion of a $25 million in a Series C funding, led by a global strategic leader in the ophthalmic industry and CR-CP Life Science Fund. Other participan... |
| 15.03.2021 | EyeYon Medical Raises $25M in Series C Funding | EyeYon Medical, a Tel Aviv, Israel-based company that develops advanced technology to treat acute problems in the ophthalmic world, closed a $25m Series C funding round. The round, which brings the company’s valuation to $36m, was led by a ... |
| 21.03.2017 | Israeli medtech startup EyeYon raises $6.5 million for its synthetic corneas | Israeli medical equipment company EyeYon Medical announced that it has completed a Series B financing round of $6.5 million. The round was led by the Chinese fund Rimonci Capital, a joint venture representing China’s largest private ophthal... |